Merck buys experimental tau antibody from Teijin

26th May 2017 Uncategorised 0

Merck & Co has bought itself an exclusive global licence from Teijin Pharma to develop, manufacture and commercialise an investigational preclinical antibody candidate targeting a protein called tau.

More: Merck buys experimental tau antibody from Teijin
Source: News